Diagnostic Performance of Three Serological Assays for Anti-SARS-CoV-2 Antibody Detection

Authors

  • Shabnam Dildar Department of Pathology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Asma Danish Department of Hematology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Mehjabeen Imam Department of Pathology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Arshi Naz Department of Pathology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.
  • Tahir Sultan Shamsi Department of Hematology, National Institute of Blood Disease & Bone Marrow Transplantation, Karachi, Pakistan.

Keywords:

Convalescent plasma donors, Immunofluorescence, Electrochemiluminescence, immunosorbent

Abstract

Abstract: Objective: To evaluate the diagnostic performance of Electrochemiluminescence (ECLIA) enzyme linked immunosorbent (ELISA) and lateral flow Immunofluorescence (LFIA) for anti-SARS-COV-2 antibody detection.

Materials and Methods: Sensitivity was calculated with convalescent plasma (CP) donor’s samples. Specificity was checked by using pre-pandemic October 2019 samples. All samples were tested for anti-SARS-COV-2 antibody by using Electrochemiluminescence (ECLIA), Enzyme Linked Immunosorbent Assay (ELISA) and Lateral flow Immunofluorescence (LFIA) assay.
Results: Total 55 patients were included, 45 patients were CP donors and 10 were Pre-Pandemic October 2019 samples archived from our blood bank. The ECLIA-total antibody, ELISA-IgG and LLFIA-IgG were positive in 41 (91.1%), 34 (75.5%) and 44 (97.75%) respectively. The highest sensitivity was observed for LFIA with highest specificity among all three assays. There was almost perfect agreement between LFIA and ECLIA (k=0.936, p<0.001) but there was fair agreement between LFIA and ELISA (k=0.412, p=0.001) and ECLIA and ELISA (k=0.357, p=0.001).
Conclusion: The LFIA showed a higher sensitivity and specificity in comparison with ECLIA and ELISA. It might be due to fact that LFIA detect antibody against ncleocapsid and spike protein as well of SARS- COV-2 virus, while ECLIA and ELISA detects antibodies only against “N” Protein of SARS- COV-2 virus.

Downloads

Published

2021-07-26

How to Cite

1.
Dildar S, Danish A, Imam M, Naz A, Shamsi TS. Diagnostic Performance of Three Serological Assays for Anti-SARS-CoV-2 Antibody Detection. Nat J Health Sci [Internet]. 2021Jul.26 [cited 2021Sep.18];5(4):162-5. Available from: https://ojs.njhsciences.com/index.php/njhs/article/view/182

Issue

Section

Research Article

Most read articles by the same author(s)

1 2 3 > >>